DE69902537T2 - Eine verbindung, wf002, ein verfahren zu ihrer herstellung und ihre verwendung - Google Patents

Eine verbindung, wf002, ein verfahren zu ihrer herstellung und ihre verwendung

Info

Publication number
DE69902537T2
DE69902537T2 DE69902537T DE69902537T DE69902537T2 DE 69902537 T2 DE69902537 T2 DE 69902537T2 DE 69902537 T DE69902537 T DE 69902537T DE 69902537 T DE69902537 T DE 69902537T DE 69902537 T2 DE69902537 T2 DE 69902537T2
Authority
DE
Germany
Prior art keywords
compound
production
medicament
connection
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69902537T
Other languages
English (en)
Other versions
DE69902537D1 (de
Inventor
Yasuhiro Hori
Masami Ezaki
Yasuhisa Tsurumi
Shigehiro Takase
Motohiro Hino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69902537D1 publication Critical patent/DE69902537D1/de
Publication of DE69902537T2 publication Critical patent/DE69902537T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Botany (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coupling Device And Connection With Printed Circuit (AREA)
  • Adornments (AREA)
  • Manufacturing Of Electrical Connectors (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DE69902537T 1998-06-23 1999-06-16 Eine verbindung, wf002, ein verfahren zu ihrer herstellung und ihre verwendung Expired - Fee Related DE69902537T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP4293A AUPP429398A0 (en) 1998-06-23 1998-06-23 A compound, WF002, production thereof and use thereof
PCT/JP1999/003191 WO1999067272A1 (en) 1998-06-23 1999-06-16 A compound, wf002, production thereof and use thereof

Publications (2)

Publication Number Publication Date
DE69902537D1 DE69902537D1 (de) 2002-09-19
DE69902537T2 true DE69902537T2 (de) 2003-01-09

Family

ID=3808536

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69902537T Expired - Fee Related DE69902537T2 (de) 1998-06-23 1999-06-16 Eine verbindung, wf002, ein verfahren zu ihrer herstellung und ihre verwendung

Country Status (8)

Country Link
US (1) US6521600B1 (de)
EP (1) EP1087987B1 (de)
JP (1) JP2002518515A (de)
AT (1) ATE222260T1 (de)
AU (1) AUPP429398A0 (de)
DE (1) DE69902537T2 (de)
ES (1) ES2179668T3 (de)
WO (1) WO1999067272A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105483023B (zh) * 2015-12-23 2019-06-21 广西大学 越南槐内生真菌grph-0在防治白色念珠菌中的应用

Also Published As

Publication number Publication date
ATE222260T1 (de) 2002-08-15
EP1087987A1 (de) 2001-04-04
US6521600B1 (en) 2003-02-18
WO1999067272A1 (en) 1999-12-29
JP2002518515A (ja) 2002-06-25
EP1087987B1 (de) 2002-08-14
AUPP429398A0 (en) 1998-07-16
DE69902537D1 (de) 2002-09-19
ES2179668T3 (es) 2003-01-16

Similar Documents

Publication Publication Date Title
CA2183972A1 (en) Oxazolidinone derivatives and pharmaceutical compositions containing them
EP2266620A3 (de) Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
TR200302214T4 (tr) Psoriasis tedavisi için kullanilan pteridine bileşkenleri
CA2501799A1 (en) Pyrazole compounds for treatment of neurodegenerative disorders
DE60202958D1 (de) Stabiles polymorph von flibanserin, industrielles verfahren zu dessen herstellung und dessen verwendung zur herstellung von medikamenten
DE60034240D1 (de) Drogen zur behandlung maligner tumoren
DE60112330D1 (en) Pyrazolopyridinderivate
ATE301117T1 (de) Neue cyclopropane als cgrp-antagonisten, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
SE9804212D0 (sv) Compounds
IL157540A (en) Pharmaceutical compositions comprising n-(aryl)-2-arylethenesulfonamides, some such novel compounds and process for their preparation
HK1046902A1 (zh) 新型哌嗪基烷基硫代嘧啶衍生物，包含該衍生物的藥物組合物以及製備該活性物質的方法
ATE310010T1 (de) 6-0-substitutierte eryththromycin-verbindungen und verfahrenen zu ihrer herstellung
NZ515108A (en) Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments
MX9604762A (es) Nuevas sulfonamidas y procedimiento para su preparacion.
DE69917668D1 (de) Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung
DE69902537T2 (de) Eine verbindung, wf002, ein verfahren zu ihrer herstellung und ihre verwendung
ATE307809T1 (de) Neuartige pyrimidin-derivate und verfahren zu ihrer herstellung
PL338348A1 (en) Thiazolobenzenoheterocyclic compounds, their production and drugs containing them
DE69815854D1 (de) Polyhydroxybutylpyrazinen, deren herstellung und diese enthaltende arzneimitteln
UY26435A1 (es) Compuestos bis-básicos como inhibidores de triptasa, procedimiento para su preparación y su utilización como medicamentos.
DE60000790D1 (de) [(2-substituierte-5-[3-thienyl)-benzyl]-[2-([2-isopropoxy-5-fluoro]-phenoxy)-ethyl]-amine, verfahren zu ihrer herstellung und ihre verwendung als medikamente
DE69706441D1 (de) Tetracyclische aromatische retinoide verbindungen, ihre herstellung und verwendung
MXPA04001856A (es) Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos.
MXPA04001852A (es) Uso de sistemas indan-1-ol c2-sustituidas para la produccion de medicamentos para la profilaxis o tratamiento de obesidad.
MXPA04001846A (es) Indan-1-onas c2-substituidas y sus derivados, metodos para su produccion y su uso como medicamentos.

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee